Hedge Fund Database
The curated database of hedge funds that publish investor letters. Research by geography, strategy, and schools of thought.
| # | Fund | Strategy | Style | Geography | AUM | Latest Letter |
|---|---|---|---|---|---|---|
The curated database of hedge funds that publish investor letters. Research by geography, strategy, and schools of thought.
| # | Fund | Strategy | Style | Geography | AUM | Latest Letter |
|---|---|---|---|---|---|---|
As of Dec 31, 2025
In his 2025 annual letter, Guy Spier announces the difficult decision to close the Aquamarine Fund to external investors and return approximately $235 million (about 50% of the fund's $470 million AUM). The decision follows a diagnosis and recurrence of grade 4 glioblastoma (GBM). Spier reports that in 2025, the fund returned 11.3% compared to 17.9% for the S&P 500. He outlines the orderly liquidation process, shares personal reflections on his 28-year investing career, and offers a five-point framework for selecting investment stewards (skin in the game, sole focus, run as an activity rather than a business, competence/candor, and the fiduciary gene). Going forward, the fund will transition to a family office, concentrating strictly on durable compounders like Berkshire Hathaway, Nestlé, and Mastercard.
True compounding success comes from selecting durable, time-friendly businesses managed by leaders with skin in the game, absolute focus, and a strong fiduciary gene, while systematically avoiding cyclical and binary-outcome risks.
The manager is winding down external capital and moving the remaining portfolio toward a low-maintenance, long-term approach focused on inevitable, durable compounders. This style allows him to devote more of his time and focus to his health and family, while still running the family office portfolio.
High Conviction Bullish
Market Conviction
Growth Outlook
Risk Appetite
Capital Deployment
Forward Guidance
Language Signal
Perceived Risk
Opportunity Density
Time Horizon
Top Conviction Themes
Key Catalysts
Every insight in this database connects to the original source. Read the actual thesis, see the actual concerns, and make your own call.
Buyside Digest has no business relationship, partnership, agency, sponsorship, endorsement, or affiliation with Aquamarine or any other manager whose content appears on the Service, except where expressly stated. We do not receive Manager Content directly from managers in most cases; content is collected from publicly available sources. Managers have not necessarily reviewed, approved, authorized, or endorsed our display of their content, our editorial commentary, our metadata extraction, or our classifications. Use of a manager’s name is for accurate attribution and identification purposes only, under principles of nominative fair use.
Buyside Digest does not independently verify the regulatory status, registrations, licensing, qualifications, credentials, or professional standing of managers whose content appears on the Service. We do not represent that managers are properly registered with applicable regulatory bodies, that their content complies with applicable securities laws, or that their performance representations are accurate. Inclusion of a manager in our database is based on the publicly available nature of their content, not on our verification of their regulatory status or content compliance. Users are responsible for conducting their own due diligence on any manager.
Performance data, returns, assets under management (“AUM”), and similar figures displayed on this page are sourced from publicly available manager communications (including investor letters), public filings, or other third-party sources. Buyside Digest does not independently verify performance figures, calculate returns, or audit manager-reported data. Such figures: May be selectively reported by the manager; May use non-standard calculation methodologies; May not reflect fees, expenses, taxes, or other costs; May be inconsistent across reporting periods; May be outdated. Past performance is not indicative of future results. Performance figures should not be relied upon for investment decisions without independent verification. Users should request audited performance data directly from the manager and conduct their own due diligence.